🔬 Focusing on delivering the world's latest scientific research, authoritative clinical trial results and industry policy interpretation, covering neural stem cell transplantation, mesenchymal stem cells, immune cell therapy (e.g. CAR-T) and other cutting-edge technologies. ⚡

拜耳 - 杭吉干细胞生命科技

拜耳公司帕金森病干细胞新药bemdaneprocel进入关键性3期临床，完成首例患者给药

Progress on new drugs

Bayer's new Parkinson's stem cell drug bemdaneprocel enters pivotal Phase 3 clinic, completes first patient dosing

2025-09-24 阅读(599) Author (admin)

图片来源：Elena Krivorotova / Shutterstock.com 近日，拜耳公司公布了其在帕金森病（PD）领域的两项在研疗法的重要进展。2025年9月22日，拜耳旗下临床阶段细胞治疗公司BlueRock Therapeutics LP宣布，其……